Cart
sales@molnova.com
Valorphin TFA
CAS No. ——
Valorphin TFA( —— )
Catalog No. M21005 CAS No. ——
Valorphin TFA is a semisynthetic derivative of dihydrovaltrate with opioid analgesic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 76 | Get Quote |
|
| 5MG | 109 | Get Quote |
|
| 10MG | 160 | Get Quote |
|
| 25MG | 323 | Get Quote |
|
| 50MG | 494 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameValorphin TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionValorphin TFA is a semisynthetic derivative of dihydrovaltrate with opioid analgesic activity.
-
DescriptionValorphin TFA is a semisynthetic derivative of dihydrovaltrate with opioid analgesic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1006.03
-
Molecular FormulaC46H62F3N9O13
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C.O=C(O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maurer R R?Mer D H.H. Büscher et al. Valorphin: A novel chemical structure with opioid activity[J]. Neuropeptides 1985 5(4-6):387-390.
molnova catalog
related products
-
Cisd2 agonist 1
Cisd2 agonist 1 is a potent CDGSH iron-sulfur structural domain 2 (CISD2) agonist (EC50: 34 nM) with potential anticancer activity for the study of non-alcoholic fatty liver disease (NAFLD).
-
Biotin-PEG6-Boc
Biotin-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Leuprolide Acetate
Leuprolide is an agonist at pituitary GnRH receptors. Leuprorelin is a gonadotropin-releasing hormone (GnRH) analog used to treat a wide range of sex hormone-related disorders including advanced prostatic cancer endometriosis and precocious puberty.
